Our cosmetic ingredient development team is prepared to lead discussions on next-generation cosmetics at SCS Formulate 2024, scheduled…
Menu
On November 4-6, Aistė Jekabsone, CEO of Exolitus, will attend BIO-Europe 2024 in Stockholm, Sweden, a premier partnering…
Exolitus is excited to announce participation of CEO Aiste Jekabsone and BDM Kestutis Andriulaitis in the LSX Nordic…
???? Whoosh, it’s Exolitus skyrocketing to London Biotechnology Show 2024! ???? Join us on May 9th for an…
Exolitus team is looking forward to partnering meetings at BIO International Convention 2023, which will take place on…
❔ So, what are exosomes and extracellular vesicles❔ We are happy to share our animated story with all…
Last week Exolitus was recognized as The Most Innovative Biotechnology Solution of the Year at Kaunas Startup Awards…
We are feeling grateful and motivated more than ever as our company was certified as „A“ class leader…
Cardiovascular disease, which causes ischemic injury, is the leading cause of death worldwide. During heart surgery, the myocardium…
During the past couple of years, COVID-19 has been probably the most popular theme for discussions. Unfortunately, despite…